Lenalidomide as a novel treatment of acute myeloid leukemia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.3, 2013-03, pp. : 389-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel and Emerging Drugs for Acute Myeloid Leukemia

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 522-530

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Raf Kinase in the Treatment of Acute Myeloid Leukemia

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2243-2248

Bentham Science Publishers

Access to resources Recommend Favorite

The role of quizartinib in the treatment of acute myeloid leukemia

By Ostronoff Fabiana Estey Elihu

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1659-1669

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies for the Treatment of Acute Myeloid Leukemia

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 343-369

Bentham Science Publishers

Access to resources Recommend Favorite

Perifosine – a new option in treatment of acute myeloid leukemia?

By Krawczyk Janusz Keane Niamh Swords Ronan O'Dwyer Michael Freeman Ciara L Giles Francis J

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1315-1327

Informa Healthcare

Access to resources Recommend Favorite